APOE2 Heterozygosity Reduces Hippocampal Soluble Amyloid-beta42 Levels in Non-Hyperlipidemic Mice. Valencia-Olvera AC, Balu D, Moore A, Shah M, et al. J Alzheimers Dis 2024;97:1629-1639.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Valencia-Olvera AC, Balu D, Moore A, Shah M, et al. APOE2 Heterozygosity Reduces Hippocampal Soluble Amyloid-beta42 Levels in Non-Hyperlipidemic Mice. J Alzheimers Dis 2024;97:1629-1639.
PMID: 38306049